The Crucial Role of Diet Therapy and Selenium on the Evolution of Clinical and Paraclinical Parameters in Patients with Metabolic Syndrome

Table 1

The statistical description of the baseline data for the clinical parameters.

Parameters			Groups
			LC	LD	LD + Se
			n (%)	n (%)	n (%)
BMI mean/SD			30, 93 (6, 98)	31, 52 (6, 71)	31, 23 (9, 34)	0.912
Obesity	Underweight		0 (0, 0%)	4 (3, 4%)	0 (0, 0%)	0.506
	Normal		4 (11, 4%)	17 (14, 3%)	16 (30, 8%)
	Overweight		18 (51, 4%)	20 (16, 8%)	13 (25, 0%)
	Obesity degree 1		4 (11, 4%)	45 (37, 8%)	10 (19, 2%)
	Obesity degree 1		2 (5, 7%)	24 (20, 2%)	3 (5, 8%)
	Obesity degree 1		7 (20, 0%)	8 (6, 7%)	10 (19, 2%)
Sarcopenia index mean/SD			8, 69 (1, 57)	8, 20 (1, 91)	7, 95 (1, 72)	0.168
Cardiovascular diseases		No	30 (85, 7%)	82 (68, 9%)	36 (69, 2%)	0.136
		Yes	5 (14, 3%)	37 (31, 1%)	16 (30, 8%)
Fat mass mean/SD			31, 87 (8, 53)	33, 78 (6, 89)	25, 82 (9, 33)	0.001
Visceral fat			8, 74 (5, 78)	9, 33 (6, 39)	5, 35 (3, 97)	0.001

n = number of patients, SD = standard deviation, BMI = body mass index, and  = statistically significance.